在使用莱维他治疗后牙扩大:临床病例分析
Awadh M Alahmari1,2,3, Ali M Alkhathaami3,4,5
1Department of Neurology, King Saud Bin Abdulaziz University for Health Science (KSAU-HS), Riyadh, Saudi Arabia.
Epilepsia open
|August 6, 2025
概括
类药物莱维他可以导致牙扩大,这是牙过度生长的副作用. 本病例报告强调在接受 levetiracetam 治疗的患者中监测这种不良事件.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 口腔医学是指口腔医学.
背景情况:
- 的治疗通常涉及抗药物.
- 列维是一种常见的抗药物.
- 牙扩大是某些药物的已知,尽管不常见的副作用.
研究的目的:
- 在接受 levetiracetam 治疗的患者中报告牙扩大病例.
- 强调识别和监测这种不良药物反应的重要性.
- 讨论 levetiracetam 诱导的牙扩张的临床影响和管理.
主要方法:
- 一个21岁的女性患有的病例报告.
- 开始服用乙的治疗剂量为每天两次750毫克以控制发作.
- 进行的临床检查,实验室检测和遗传检测.
- 列维基拉塞坦被逐渐缩小并切换为拉莫特里金.
主要成果:
- 患者出现了显著的牙扩张,尽管有令人满意的控制.
- 没有发现其他有助于导致牙扩大的因素或遗传倾向.
- 为了控制副作用,考虑过渡到拉莫特里金.
- 建议进行外科手术以改善美容.
结论:
- 牙扩大是 levetiracetam 的潜在不良影响,需要临床关注.
- 医疗保健提供者应就这种副作用向患者提供建议,并监测其发展.
- 早期识别和适当的管理,包括药物调整至关重要.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
450
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
450
Antiepileptic Drugs: Potassium Channel Activators
278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
278
Aneurysm II: Clinical Manifestations and Diagnostic Studies
23
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
23
Seizures: Classification
593
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
593
Antiepileptic Drugs: Glutamate Antagonists
516
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
516
Epilepsy and Seizures: Overview
280
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
280


